Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

UBS Maintains Neutral on NetApp, Lowers Price Target to $78

UBS analyst David Vogt maintains NetApp (NASDAQ:NTAP) with a Neutral and lowers the price target from $91 to $78.
byBenzinga Newsdesk
July 29, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

UBS analyst David Vogt maintains NetApp (NASDAQ:NTAP) with a Neutral and lowers the price target from $91 to $78.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Arcutis Biotherapeutics Says STRATUM Study Met Its Primary Endpoint, With Nearly 80% Of ZORYVE Foam Treated Individuals Reaching Investigator Global Assessment; Also Demonstrated Improvement On All Secondary Endpoints, Including Itch, Scaling And Eryth…

By Benzinga Newsdesk
December 16, 7:57 PM
ZORYVE Foam Clinical DataThe approval is supported by positive results from Arcutis' Phase 2 and pivotal Phase 3 trials in seborrheic dermatitis. The STudy of Roflumilast

ARQT